Loading viewer...
earnings
Format: PDF earnings
ProMetic Life Sciences presented Q3 2016 results and strategic updates on its biopharmaceutical pipeline spanning small molecule drugs and plasma protein therapies. The presentation outlines the company's clinical programs including Plasminogen, IVIG, and PBI-4050, alongside financial performance and cash runway analysis as it gears toward the commercial phase.
investor_presentation
24 Pages
earnings
39 Pages
Beach Energy
A.P. Møller - Mærsk Q3 2016 Interim Report
earningsearnings
41 Pages
A.P. Møller - Mærsk A/S
Hayward Holdings Q3 2022 Earnings Call Presentation
earningsearnings
23 Pages
Hayward Holdings, Inc.